Green Cross Lab Cell Corporation (144510) — Cash Flow Reinvestment Rate
Green Cross Lab Cell Corporation (144510) has a Cash Flow Reinvestment Rate of 0.30x as of September 2025, reinvesting ₩2.01 Billion (capex ₩624.50 Million plus investments ₩-1.38 Billion) from operating cash flow of ₩6.67 Billion. Check Green Cross Lab Cell Corporation (144510) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Green Cross Lab Cell Corporation Cash Flow Reinvestment Rate (2015–2024)
Historical reinvestment intensity for Green Cross Lab Cell Corporation across 9 annual periods. Explore Green Cross Lab Cell Corporation (144510) investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Green Cross Lab Cell Corporation (2015–2024)
Year-by-year capital reinvestment analysis for Green Cross Lab Cell Corporation. For live market cap and broader valuation context, see Green Cross Lab Cell Corporation (144510) total market value.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.47x | ₩16.65 Billion | ₩11.34 Billion | ₩6.03 Billion | ▼ -89.8% |
| 2023 | 14.36x | ₩52.70 Billion | ₩3.67 Billion | ₩18.40 Billion | ▲ +2799.7% |
| 2022 | 0.50x | ₩32.88 Billion | ₩66.42 Billion | ₩6.91 Billion | ▼ -60.5% |
| 2021 | 1.25x | ₩29.96 Billion | ₩23.91 Billion | ₩10.88 Billion | ▼ -16.0% |
| 2020 | 1.49x | ₩13.57 Billion | ₩9.09 Billion | ₩4.79 Billion | ▼ -96.1% |
| 2019 | 38.67x | ₩8.62 Billion | ₩223.04 Million | ₩5.34 Billion | ▲ +84.7% |
| 2018 | 20.94x | ₩10.28 Billion | ₩490.92 Million | ₩4.78 Billion | ▲ +47.9% |
| 2017 | 14.16x | ₩40.51 Billion | ₩2.86 Billion | ₩1.78 Billion | ▲ +1115.2% |
| 2015 | 1.17x | ₩1.73 Billion | ₩1.49 Billion | ₩833.86 Million | — |